ELLIPTA Dry Powder Inhaler
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ELLIPTA Dry Powder Inhaler, covering 2017-06-22 to 2019-10-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease [Phase 4]